lactic acid has been researched along with Mucopolysaccharidosis II in 1 studies
Lactic Acid: A normal intermediate in the fermentation (oxidation, metabolism) of sugar. The concentrated form is used internally to prevent gastrointestinal fermentation. (From Stedman, 26th ed)
2-hydroxypropanoic acid : A 2-hydroxy monocarboxylic acid that is propanoic acid in which one of the alpha-hydrogens is replaced by a hydroxy group.
Mucopolysaccharidosis II: Systemic lysosomal storage disease marked by progressive physical deterioration and caused by a deficiency of L-sulfoiduronate sulfatase. This disease differs from MUCOPOLYSACCHARIDOSIS I by slower progression, lack of corneal clouding, and X-linked rather than autosomal recessive inheritance. The mild form produces near-normal intelligence and life span. The severe form usually causes death by age 15.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Salvalaio, M | 1 |
| Rigon, L | 1 |
| Belletti, D | 1 |
| D'Avanzo, F | 1 |
| Pederzoli, F | 1 |
| Ruozi, B | 1 |
| Marin, O | 1 |
| Vandelli, MA | 1 |
| Forni, F | 1 |
| Scarpa, M | 1 |
| Tomanin, R | 1 |
| Tosi, G | 1 |
1 other study available for lactic acid and Mucopolysaccharidosis II
| Article | Year |
|---|---|
Targeted Polymeric Nanoparticles for Brain Delivery of High Molecular Weight Molecules in Lysosomal Storage Disorders.
Topics: Albumins; Animals; Blood-Brain Barrier; Disease Models, Animal; Drug Carriers; Enzyme Replacement Th | 2016 |